OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 5, pp. 100737-100737
Open Access | Times Cited: 89
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 5, pp. 100737-100737
Open Access | Times Cited: 89
Showing 1-25 of 89 citing articles:
The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy
Mohamed Bakr Zaki, Ahmed I. Abulsoud, Shereen Saeid Elshaer, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154437-154437
Closed Access | Times Cited: 48
Mohamed Bakr Zaki, Ahmed I. Abulsoud, Shereen Saeid Elshaer, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154437-154437
Closed Access | Times Cited: 48
Photodynamic Therapy in Cancer: Insights into Cellular and Molecular Pathways
Vincenzo Papa, Fabiana Furci, Paola Lucia Minciullo, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 69-69
Open Access | Times Cited: 1
Vincenzo Papa, Fabiana Furci, Paola Lucia Minciullo, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 69-69
Open Access | Times Cited: 1
Advances in targeted therapy of cholangiocarcinoma
Yuhang Li, Jianfeng Yu, Yujing Zhang, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 12
Yuhang Li, Jianfeng Yu, Yujing Zhang, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 12
Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches
Divya Khosla, Shagun Misra, Pek Lim Chu, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 801-801
Open Access | Times Cited: 11
Divya Khosla, Shagun Misra, Pek Lim Chu, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 801-801
Open Access | Times Cited: 11
IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced Cholangiocarcinoma
Haijiao Yan, Qian Deng, Yu Meng, et al.
Cancer Biotherapy and Radiopharmaceuticals (2025)
Closed Access | Times Cited: 1
Haijiao Yan, Qian Deng, Yu Meng, et al.
Cancer Biotherapy and Radiopharmaceuticals (2025)
Closed Access | Times Cited: 1
Expression of MUC1 in different tumours and its clinical significance (Review)
Yue Lan, Weihua Ni, Guixiang Tai
Molecular and Clinical Oncology (2022) Vol. 17, Iss. 6
Open Access | Times Cited: 31
Yue Lan, Weihua Ni, Guixiang Tai
Molecular and Clinical Oncology (2022) Vol. 17, Iss. 6
Open Access | Times Cited: 31
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review
Alessandra Elvevi, Alice Laffusa, Camilla Gallo, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 370-370
Open Access | Times Cited: 19
Alessandra Elvevi, Alice Laffusa, Camilla Gallo, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 370-370
Open Access | Times Cited: 19
Liver Organoids as an In Vitro Model to Study Primary Liver Cancer
Silvia De Siervi, Cristian Turato
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4529-4529
Open Access | Times Cited: 15
Silvia De Siervi, Cristian Turato
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4529-4529
Open Access | Times Cited: 15
Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25
Hyeseon Yun, Hong‐Rae Jeong, Do Yeon Kim, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 3
Open Access | Times Cited: 4
Hyeseon Yun, Hong‐Rae Jeong, Do Yeon Kim, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 3
Open Access | Times Cited: 4
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma
Xu Chen, Bo Sun, Yu Chen, et al.
Translational Oncology (2024) Vol. 43, pp. 101905-101905
Open Access | Times Cited: 4
Xu Chen, Bo Sun, Yu Chen, et al.
Translational Oncology (2024) Vol. 43, pp. 101905-101905
Open Access | Times Cited: 4
Umbrella review of adjuvant photodynamic therapy for cholangiocarcinoma palliative treatment
Hanhan Chen, Honglin Li, Huijie Li, et al.
Photodiagnosis and Photodynamic Therapy (2025) Vol. 51, pp. 104472-104472
Open Access
Hanhan Chen, Honglin Li, Huijie Li, et al.
Photodiagnosis and Photodynamic Therapy (2025) Vol. 51, pp. 104472-104472
Open Access
LncRNA MIR17HG drives cisplatin resistance partially via miR-138-5p/AKAP9 axis in cholangiocarcinoma
Ling‐Yu Tang, Yuting Wang, Yongzhen Chen, et al.
Scandinavian Journal of Gastroenterology (2025), pp. 1-13
Closed Access
Ling‐Yu Tang, Yuting Wang, Yongzhen Chen, et al.
Scandinavian Journal of Gastroenterology (2025), pp. 1-13
Closed Access
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study
Aung Naing, Amit Mahipal, Milind Javle, et al.
Journal of Immunotherapy and Precision Oncology (2025) Vol. 8, Iss. 1, pp. 71-81
Open Access
Aung Naing, Amit Mahipal, Milind Javle, et al.
Journal of Immunotherapy and Precision Oncology (2025) Vol. 8, Iss. 1, pp. 71-81
Open Access
Efficacy analysis of drug-eluting beads transcatheter arterial chemoembolization combining systemic chemotherapy and immune checkpoint inhibitors in unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study based on propensity score matching
Song Liu, Qingdong Wang, Yin Shunhang, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Song Liu, Qingdong Wang, Yin Shunhang, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Characteristics of gut microbiota and metabolites in extrahepatic cholangiocarcinoma and their prognostic value for resectable lesions
Cheng Ye, Bo Zhang, Yanyan Lin, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Cheng Ye, Bo Zhang, Yanyan Lin, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions
Silvia Camera, Federico Rossari, Silvia Foti, et al.
Targeted Oncology (2025)
Closed Access
Silvia Camera, Federico Rossari, Silvia Foti, et al.
Targeted Oncology (2025)
Closed Access
The Global and Regional Burden of Gallbladder and Biliary Tract Cancer and Attributable Risk Factors: Trends and Predictions
Shuping Qiu, Wanting Zeng, Jilin Zhang, et al.
Liver International (2025) Vol. 45, Iss. 4
Closed Access
Shuping Qiu, Wanting Zeng, Jilin Zhang, et al.
Liver International (2025) Vol. 45, Iss. 4
Closed Access
Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma
Sirinya Sitthirak, Arporn Wangwiwatsin, Apinya Jusakul, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Sirinya Sitthirak, Arporn Wangwiwatsin, Apinya Jusakul, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A meta-analysis of prognostic factors for early recurrence in perihilar cholangiocarcinoma after curative-intent resection
Yuan Tian, Ningyuan Wen, Bei Li, et al.
European Journal of Surgical Oncology (2023) Vol. 49, Iss. 11, pp. 106982-106982
Closed Access | Times Cited: 9
Yuan Tian, Ningyuan Wen, Bei Li, et al.
European Journal of Surgical Oncology (2023) Vol. 49, Iss. 11, pp. 106982-106982
Closed Access | Times Cited: 9
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma
Wei Zhang, Shuai Wang
Melanoma Research (2024)
Closed Access | Times Cited: 3
Wei Zhang, Shuai Wang
Melanoma Research (2024)
Closed Access | Times Cited: 3
Causal roles of gut microbiota in cholangiocarcinoma etiology suggested by genetic study
Zhitao Chen, Chenchen Ding, Kailei Chen, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1319-1333
Open Access | Times Cited: 3
Zhitao Chen, Chenchen Ding, Kailei Chen, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1319-1333
Open Access | Times Cited: 3
Novel definition of textbook outcome in biliary system cancers and its influence on patients' survival and quality of life
Manar Atyah, Li Xu, Zhiying Yang
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 3
Manar Atyah, Li Xu, Zhiying Yang
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 3
Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein
Putthaporn Kaewmeesri, Piman Pocasap, Veerapol Kukongviriyapan, et al.
Integrative Cancer Therapies (2022) Vol. 21
Open Access | Times Cited: 14
Putthaporn Kaewmeesri, Piman Pocasap, Veerapol Kukongviriyapan, et al.
Integrative Cancer Therapies (2022) Vol. 21
Open Access | Times Cited: 14
Cholangiocarcinoma in the Era of Immunotherapy
Eleni Manthopoulou, Daryl Ramai, Jahnvi Dhar, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1062-1062
Open Access | Times Cited: 8
Eleni Manthopoulou, Daryl Ramai, Jahnvi Dhar, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1062-1062
Open Access | Times Cited: 8
Locoregional Approaches in Cholangiocarcinoma Treatment
Alexander E. Hare, Mina S. Makary
Cancers (2022) Vol. 14, Iss. 23, pp. 5853-5853
Open Access | Times Cited: 12
Alexander E. Hare, Mina S. Makary
Cancers (2022) Vol. 14, Iss. 23, pp. 5853-5853
Open Access | Times Cited: 12
